More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of pseudomonas aeruginosa infections: A case report

Journal of Medicinal Food

Volumn 10, Issue 2, 2007, Pages 375-378

  Nilsson, Elin ^a   Kollberg, Hans ^a   Johannesson, Marie ^a   Wejåker, Per Erik ^a   Carlander, David ^a   Larsson, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibody; Chicken; Cystic fibrosis; Egg; Immunoglobulin; Immunoglobulin Y; Immunotherapy; Pseudomonas aeruginosa; Yolk

Indexed keywords

IMMUNOGLOBULIN Y;

ABSENCE OF SIDE EFFECTS; ARTICLE; BACTERIAL COLONIZATION; CASE REPORT; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOTHERAPY; INFECTION PREVENTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANIMALS; CHICKENS; CYSTIC FIBROSIS; EGG YOLK; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LUNG DISEASES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

ANIMALIA; PSEUDOMONAS AERUGINOSA;

EID: 34547114490     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.214     Document Type: Article

References (34)

1. Bartz CR, Conklin RH, Tunstall CB, Steele JH: Prevention of murine rotavirus infection with chicken egg yolk immunoglobulins. J Infect Dis 1980;142:439-441.
2. Hamada S, Horikoshi T, Minami T, Kawabata S, Hiraoka J, Fujiwara T, Ooshima T: Oral passive immunization against dental caries in rats by use of hen egg yolk antibodies specific for cell-associated glucosyltransferase of Streptococcus mutans. Infect Immun 1991;59:4161-4167.
3. Kuroki M, Ohta M, Ikemori Y, Peralta RC, Yokoyama H, Kodama Y: Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch Virol 1994;138:143-148.
4. Otake S, Nishihara Y, Makimura M, Hatta H, Kim M, Yamamoto T, Hirasawa M: Protection of rats against dental caries by passive immunization with hen-egg-yolk antibody (IgY). J Dent Res 1991;70:162-166.
5. Hatta H, Tsuda K, Ozeki M, Kim M, Yamamoto T, Otake S, Hirasawa M, Katz J, Childers NK, Michalek SM: Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res 1997;31:268-274.
6. Rose ME, Orlans E: Immunoglobulins in the egg, embryo and young chick. Dev Comp Immunol 1981;5:15-20.
7. Larsson A, Bålöw RM, Lindahl TL, Forsberg PO: Chicken antibodies: taking advantage of evolution - a review. Poult Sci 1993;72:1807-1812.
8. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
9. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
10. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-1065.
11. Ramsey BW: Drug therapy: management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-188.
12. Shale DJ, Elborn JS: Lung injury. In: Cystic Fibrosis (Shale DJ, ed.), BMJ Publishing Group, London, 1996, pp. 62-78.
13. Grimwood K, Armstrong D, Carlin J, Carzino R, Kyd J, Moore R, Olinsky A: Acquisition of Pseudomonas aeruginosa in young infants. Pediatr Pulmonol 1997;(Suppl 14):133-134.
14. Akita EM, Nakai S: Immunoglobulins from egg yolk: isolation and purification. J Food Sci 1992;57:629-634.
15. Pedersen SS, Espersen F, Hoiby N: Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol 1987;25:1830-1836.
16. Carlander D, Kollberg H, Larsson A: Duration of specific yolk IgY in the human oral cavity. Biodrugs 2002;6:433-437.
17. Gottstein B, Hemmeler E: Egg yolk immunoglobuline Y as an alternative antibody in the serology of echinococcosis. Z Parasitenkd 1985;71:273-276.
18. Kuroki M, Ikemori Y, Yokoyama H, Peralta RC, Icatlo FC Jr, Kodama Y: Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk. Vet Microbiol 1993;37:135-146.
19. Sugita-Konishi Y, Shibata K, Yun SS, Hara-Kudo Y, Yamaguchi K, Kumagai S: Immune functions of immunoglobuline Y isolated from egg yolk of hens immunized with various infectious bacteria. Biosci Biotechnol Biochem 1996;60:886-888.
20. Song CS, Yu JH, Bai DH, Hester PY, Kim KH: Antibodies to the alpha-subunit of insulin receptor from eggs of immunized hens. J Immunol 1985;135:3354-3359.
21. Larsson A, Karlsson-Parra A, Sjoquist J: Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors. Clin Chem 1991;37:411-414.
22. Masuda K, Horie K, Suzuki R, Yoshikawa T, Hirano K: Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens. Microbiol Immunol 2002;46:55-58.
23. Carlander D, Sundstrom J, Berglund A, Larsson A, Wretlind B, Kollberg H: Immunoglobuline Y (IgY) - a new tool for the prophylaxis against Pseudomonas aeruginosa in cystic fibrosis patients [abstract]. Pediatr Pulmonol 1999;(Suppl 19):240.
24. Carlander D, Olesen H, Kollberg H, Johannesson M, Wejåker P-E, Larsson A: Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: a phase I feasibility study. Pediatr Pulmonol 2003;35:433-440.
25. Tummler B, Bosshammer J, Breitenstein S, Brockhausen I, Gudowius P, Herrmann C, Herrmann S, Heuer T, Kubesch P, Mekus F, Romling U, Schmidt KD, Spangenberg C, Walter S: Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt 1997;98:249-255.
26. Pier GB: Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients. Behring Inst Mitt 1997;98:350-360.
27. Valerius NH, Koch C, Hoiby N: Prevention of chronic Pseudomonas aeruginosa colonization in cystic fibrosis by early treatment. Lancet 1991;338:725-726.
28. Rosenstein BJ, Zeitlin PL: Cystic fibrosis. Lancet 1998;351:277-282.
29. Elborn JS, Prescott RJ, Stack BH, Goodchild MC, Bates J, Pantin C, Ali N, Shale DJ, Crane M: Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax 2000;55:355-358.
30. Szaff M, Hoiby N, Flensborg EW: Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand 1983;72:651-657.
31. Frederiksen B, Koch C, Hoiby N: Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999;28:159-166.
32. Lindemann RA, Newman MG, Kaufman AK, Le TV: Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients. J Dent Res 1985;64:54-57.
33. Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, Touw DJ: Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-767.
34. Munck A, Bonacorsi S, Mariani-Kurkdjian P, Lebourgeois M, Gerardin M, Brahimi N, Navarro J, Bingen E: Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001;32:288-292.